Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Treatment Patterns and Healthcare Resource Utilization Following Initiation of Aripiprazole Lauroxil Using a 1-Day Initiation Regimen in Patients with Schizophrenia.
Journal: Advances in therapy
Published: February 27, 2025
Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial.
Journal: The Journal of clinical psychiatry
Published: October 05, 2022
Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis.
Journal: Molecular psychiatry
Published: July 07, 2022
Longitudinal study of inflammation and relapse in schizophrenia.
Journal: Schizophrenia research
Published: March 10, 2022
Real-World Outcomes and Costs Following 6 Months of Treatment with the Long-Acting Injectable (LAI) Aripiprazole Lauroxil for the Treatment of Schizophrenia.
Journal: CNS drugs
Published: July 17, 2021
Using Long-Acting Injectable Antipsychotics to Enhance the Potential for Recovery in Schizophrenia.
Journal: The Journal of clinical psychiatry
Published: July 02, 2020
Patient-Centered Psychopharmacology and Psychosocial Interventions: Treatment Selection and Shared Decision-Making to Enhance Chances for Recovery.
Journal: The Journal of clinical psychiatry
Published: May 16, 2020
Prevalence and Impact of Relapse in Patients With Schizophrenia.
Journal: The Journal of clinical psychiatry
Published: April 03, 2020
Managing Transitions in Care and Adherence to Improve Outcomes in Schizophrenia.
Journal: The Journal of clinical psychiatry
Published: March 29, 2019
Beyond 52-Week Long-Term Safety: Long-Term Outcomes of Aripiprazole Lauroxil for Patients With Schizophrenia Continuing in an Extension Study.
Journal: The Journal of clinical psychiatry
Published: March 15, 2019
Last Updated: 09/26/2026